Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes
Status:
Not yet recruiting
Trial end date:
2023-03-30
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to examine whether treatment with dapagliflozin plus insulin as
compared with insulin alone (basal-bolus insulin) will result in similar blood glucose
control and similar rate of complications in patients with diabetes, who are admitted to a
hospital in a noncritical setting